White label ELPA - ClinicalTrials.eu

Study Comparing Trabectedin and Gemcitabine for Patients with Advanced or Metastatic Leiomyosarcoma After Chemotherapy

Recruiting

2 1 1 1
Investigated Diseases:
- Leiomyosarcoma
- Leiomyosarcoma metastatic
Investigated Drugs:
- Gemcitabine
- Trabectedin
Study of cefuroxime and metronidazole to prevent infections after Whipple’s procedure in patients with high risk of bile contamination

Recruiting

3 1 1 1
Investigated Drugs:
- Cefuroxime
- Metronidazole
Comparison of belantamab mafodotin, bortezomib and dexamethasone versus daratumumab, bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma

Recruiting

3 1 1 1
Investigated Drugs:
+3
Study to Determine the Best Dose of Zongertinib with Trastuzumab Deruxtecan or Trastuzumab Emtansine for Patients with Advanced HER2+ Metastatic Cancer

Recruiting

1 1 1 1
Investigated Diseases:
Investigated Drugs:
Study on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)

Recruiting

3 1 1 1
Investigated Diseases:
- Chronic obstructive pulmonary disease
Investigated Drugs:
+10
Study of flecainide alone or with beta-blockers or calcium channel blockers and quinidine for treating ventricular arrhythmias in patients with Andersen-Tawil syndrome and MEPPC

Recruiting

3 1 1 1
Investigated Diseases:
- Andersen-Tawil syndrome
- Arrhythmia
Investigated Drugs:
Study on the Effectiveness and Safety of Selinexor for Patients with Myelofibrosis and Moderate Thrombocytopenia Who Have Not Used JAK Inhibitors

Recruiting

2 1 1 1
Investigated Diseases:
- Myelofibrosis
- Thrombocytopenia
Investigated Drugs:
+7
Study on Efavirenz for Patients with Early Alzheimer’s Disease

Recruiting

1 1
Investigated Diseases:
- Dementia Alzheimer’s type
Investigated Drugs:
- Efavirenz
Study on ER004 for Treating Boys with X-linked Hypohidrotic Ectodermal Dysplasia (XLHED)

Recruiting

2 1 1
Investigated Diseases:
- Congenital ectodermal dysplasia
Investigated Drugs:
- Human Immunoglobulin G1 Constant Region – Human Ectodysplasin-A1 Receptor-Binding Domain Fusion Protein
Study on the Effects of Empagliflozin, Pioglitazone, and Semaglutide for Patients with Type 2 Diabetes

Recruiting

2 1 1 1
Investigated Diseases:
- Diabetes mellitus
- Type 2 diabetes mellitus
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies